Skip to main content
Quest Diagnostics

Performance of PCR/Electrospray Ionization-Mass Spectrometry on Whole Blood for Detection of Bloodstream Microorganisms in Patients With Suspected Sepsis

Performance of PCR/electrospray ionization-mass spectrometry on whole blood for detection of bloodstream microorganisms in patients with suspected sepsis

Authors: Strålin K, Rothman RE, Özenci V, Barkataki K, Brealey D, Dhiman N, Poling L, Kurz MC, Limaye AP, LoVecchio F, Lowery K, Miller LG, Moran GJ, Overcash JS, Parekh A, Peacock WF, Rivers EP, Sims M, Stubbs AM, Sundqvist M, Ullberg M, Carroll KC.

J Clin Microbiol. 2020 Jul 8;JCM.01860-19. doi: 10.1128/JCM.01860-19. Online ahead of print.

Disclaimer: One or more of the authors of this publication were employed at the time by Med Fusion, a subsidiary of Quest Diagnostics.

Specialties: Infectious Disease

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.